Capabilities to transfer
Workflows, expertise and systems designed around your local institution.
- Oncology NGS panels
- Solid tumour and haematological panel design and validation.
- Tumour genetic testing
- Somatic and germline workflows.
- MSI, TMB, HLA profiling
- Immunotherapy biomarker readouts.
- Pathogenic gene analysis
- Inherited disease and rare variant interpretation.
- Carrier & newborn screening
- Population programme design.
- mNGS & tNGS infectious disease
- Metagenomic and targeted pathogen sequencing.
- Microbiome sequencing
- 16S and shotgun metagenomics.
- Bioinformatics support
- Pipeline transfer, validation and local hosting.
What does your institution need first?
Begin with your existing infrastructure, clinical governance and local regulatory pathway. Feasibility establishes the programme requirements.
Discussion preparation
Your institutional baseline
Use these prerequisites to prepare a discussion. This checklist is not a clinical assessment or a determination of regulatory readiness.
0 of 4discussion prerequisites identified.
Explore related partner services.
Read each service’s complete scope and regulatory note. These links help you explore the portfolio; programme-specific suitability requires feasibility assessment.
A sequencing programme starts with the question.
A research laboratory, a diagnostic service and a national genomics programme can share instruments while needing different workflows. Define the purpose first, then assess the specimen pathway, assay performance, analysis, reporting and continuing quality oversight as one programme.
CDC’s NGS Quality Initiative provides a sequencing-focused quality-management framework for clinical and public-health laboratories. Its resources address the system around a test, as well as the testing workflow.
CDC: The Next Generation Sequencing Quality InitiativeExternal references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.
Questions for the programme brief
What will the result support?
Specify the clinical or research question, the eligible population and the intended user of the report.
What needs local validation?
Request the assay scope, acceptance criteria, analysis versions and evidence for the proposed specimen types.
Who owns interpretation?
Identify laboratory review, clinical reporting, counselling or referral responsibilities and arrangements for updating findings.
What to prepare for review
- Intended-use and specimen brief
- Current instruments, staffing and quality baseline
- Example report and validation evidence to review
Working environments
Preparation. Analysis. Data infrastructure.
Illustrative stock photography provides context for the people, processes and working environments behind this capability.
Each vial highlights one planning question. The drawing is an illustrative object.
- Sample
- Which specimen types and acceptance checks are in scope?
- Method
- Which assay and analysis pipeline need local validation?
- Interpretation
- Who reviews findings and owns the final report?
